MedTrace Logo

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

NCT04977076 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1270

Last updated 2026-05-29

No results posted yet for this study

Summary

A prospective, multicenter, 1:1 randomized, investigator initiated study. Goal of this study is to examine the safety of uninterrupted periprocedural DOAC use.

Conditions

Interventions

OTHER

Uninterrupted DOAC use

Continuing DOAC use in advance of elective ICA or PCI.

OTHER

Interrupted DOAC use

Usual care, interruption of DOAC prior to procedure.

Sponsors & Collaborators

  • Zuyderland Medisch Centrum

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04977076 on ClinicalTrials.gov